This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Elsevier Publishes Open Access Journal: Computational And Structural Biotechnology Journal (CSBJ) On Behalf Of Research Network Of Computational And Structural Biotechnology

AMSTERDAM, June 2, 2014 /PRNewswire/ --

Elsevier, world-leading provider of scientific, technical and medical information products and services, and the Research Network of Computational and Structural Biotechnology (RNCSB), announce their collaborative relationship in publishing open access journal, Computational and Structural Biotechnology Journal (CSBJ) .

Computational and Structural Biotechnology Journal will be published on behalf of the Research Network of Computational and Structural Biotechnology. RNCSB is a non-profit society dedicated to the advancement of the science of biotechnology, chem-bioinformatics, systems biology and nanoscience through publication of scientific journals, organizing scientific workshops/conferences and promoting the diversity of individuals entering the advanced biotechnology scientific workforce.

Computational and Structural Biotechnology Journal is an international online-only, open access journal which publishes high quality research articles and reviews. The focus is on a functional and mechanistic understanding of how molecular components in a biological process work together through the application of computational methods. All content is indexed in PubMed Central immediately upon publication.

The Editor-in-Chief of the journal, Gianni Panagiotou, Associate Professor, at The University of Hong Kong, said of the launch, "We are pleased to work with Elsevier to publish Computational and Structural Biotechnology Journal to provide a high quality open access publishing option for authors in this important field. We are excited by this new opportunity for our authors and readers who will benefit from the breadth of Elsevier's reach and the innovative multi-media functionalities offered on ScienceDirect. We view Elsevier as being on the cutting edge in terms of their understanding of communication and the global dissemination of knowledge. At the end of the day, what makes a journal successful is: (1) the people involved, and (2) how those people connect to the broader community."

"We are delighted to announce our publishing agreement with RNCSB. For the past two years, RNCSB has applied a creative and democratic approach to open access publishing and has built a strong reputation for quality publications in this field through conference and author outreach initiatives. CSBJ will be a strong addition to Elsevier's the open access publications," said Kaia Motter, Publisher at Elsevier.

Computational and Structural Biotechnology Journal will publish its first issue with Elsevier in June 2014.

For more information or to submit an article, go to: http://ees.elsevier.com/csbj/

---

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,113.54 +61.81 0.36%
S&P 500 1,983.53 +9.90 0.50%
NASDAQ 4,456.0160 +31.3120 0.71%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs